Carmine N. Stengone is Director of KIORA PHARMACEUTICALS INC. Currently has a direct ownership of 1,250 shares of KPRX, which is worth approximately $4,662. The most recent transaction as insider was on Sep 11, 2024, when has been sold 1,250 shares (Common Stock) at a price of $3.68 per share, resulting in proceeds of $4,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.25K
n/a 3M change
n/a 12M change
Total Value Held $4,662

Carmine N. Stengone Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 11 2024
BUY
Open market or private purchase
$4,600 $3.68 p/Share
1,250 Added 50.0%
1,250 Common Stock

Also insider at

CTNM
Contineum Therapeutics, Inc.
CNS

Carmine N. Stengone

Director
Encinitas, CA

Track Institutional and Insider Activities on KPRX

Follow KIORA PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KPRX shares.

Notify only if

Insider Trading

Get notified when an Kiora Pharmaceuticals Inc insider buys or sells KPRX shares.

Notify only if

News

Receive news related to KIORA PHARMACEUTICALS INC

Track Activities on KPRX